It is now understood that specific somatic and germline mutations may lead to the
development of the neuroendocrine tumours (NETs). NETs usually occur as sporadic …

Neuroendocrine tumours (NETs) originate in tissues that contain cells derived from the
embryonic neural crest, neuroectoderm and endoderm. Thus, NETs occur at many sites in …

Inherited syndromes are important to recognize in the setting of a pancreatic
neuroendocrine tumor (PNET) as there are significant implications for the patient's medical …

Not all populations are poised to benefit from advancing genomics in
gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN), as genomics have focused …

Pancreatic neuroendocrine neoplasms (PanNENs) are the neuroendocrine neoplasms with
greatest rate of increase in incidence. Approximately 10% of PanNENs arise as inherited …

Multiple endocrine neoplasia 4 (MEN4) is a rare multiglandular endocrine neoplasia
syndrome clinically hallmarked by primary hyperparathyroidism (PHPT), pituitary adenoma …

Endocrine tumors are neoplasms arising from endocrine organs, regardless of whether the
tumor secretes hormones, and tumors producing or secreting hormones, regardless of the …

Pancreatic neuroendocrine tumors (pNETs) are characterized as a rare disease with an
incidence of less than 1 in 100,000 individuals per year, and accounts for 1% to 2% of all …

Pancreatic neuroendocrine tumors (pNETs) are uncommon cancers arising from pancreatic
islet cells. Here we report the analysis of gene mutation, copy number, and RNA expression …

Simple Summary Neuroendocrine tumors are a rare group of neoplasms characterized by
strikingly heterogeneous pathological features and clinical behavior. The incidence and …